🔎 Trials Near Me

Home › Mga Sakit ng Neurologic › North Carolina

Pag-aaral pangklinika para sa Mga Sakit ng Neurologic sa North Carolina

7 pag-aaral para sa Mga Sakit ng Neurologic ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

  • Denver, North Carolina, Denver
  • Huntersville, North Carolina, Huntersville
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07598708

Product Surveillance Registry

  • Chapel Hill
  • Charleston
  • Durham
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT01524276

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

  • Research Site, Chapel Hill
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06916806

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #067, Raleigh
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07804615

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • Duke University, Durham
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06297590

Rett Syndrome Registry

  • The University of North Carolina at Chapel Hill, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 99 · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT05432349

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Matthews
Nagre-recruitPhase 2
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT07105709

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.